Hydroxyurea therapy in highly unstable hemoglobin carriers.
Rose
C
C
Bauters
F
F
Galacteros
F
F
D000328:Adult; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005319:Fetal Hemoglobin / Q000096:biosynthesis / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects; D006411:Hematopoiesis, Extramedullary / Q000187:drug effects; D006453:Hemoglobinopathies / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006455:Hemoglobins, Abnormal / Q000737:chemistry; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D013156:Splenectomy; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control
D006455:Hemoglobins, Abnormal; D005319:Fetal Hemoglobin; D006918:Hydroxyurea